UroGen Pharma (NASDAQ:URGN – Get Free Report) and Petros Pharmaceuticals (NASDAQ:PTPI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Valuation & Earnings This table compares UroGen […]